President William Ruto has outlined a renewed push to position Kenya as a leading pharmaceutical manufacturing and health innovation hub in Africa.
President Ruto said Kenya is taking deliberate steps to strengthen its pharmaceutical ecosystem and expand local manufacturing capacity.
Speaking during the Africa Initiative for Medical Access and Manufacturing (AIM2030) meeting ahead of the Africa Forward Summit in Nairobi, the President said Kenya is taking deliberate steps to strengthen its pharmaceutical ecosystem and expand local manufacturing capacity.
The move forms part of a broader strategy aimed at reducing Africa’s dependence on imported medical products while improving access to quality and affordable healthcare solutions across the continent.
Regulatory Reforms Target Global Standards
A major pillar of the government’s plan is strengthening Kenya’s National Regulatory Authority to achieve the World Health Organisation’s Maturity Level 3 status.
According to the President, attaining the benchmark will reinforce international confidence in the quality, safety, and efficacy of pharmaceutical products manufactured in Kenya.
The certification is expected to improve the competitiveness of Kenyan-made medicines and medical products in regional and international markets. It would also position the country to attract more pharmaceutical investments and partnerships.
Kenya Eyes Regional Manufacturing Leadership
The President said Kenya’s ambition is to become a regional hub for pharmaceutical manufacturing, health innovation, and medical supply chains serving both local and wider African markets.
He pointed to Kenya’s strategic position as the gateway to Eastern Africa’s rapidly growing economic bloc as a key advantage in achieving that goal.
Ruto noted that the country is supported by a strong and expanding domestic market, improving logistics infrastructure, and an increasingly dynamic investment environment.
The government believes these factors provide a strong foundation for scaling local manufacturing and creating a more resilient healthcare supply chain.
Call for Continental Cooperation
President Ruto also urged African governments to accelerate implementation of commitments on regulatory harmonisation, industrial policy, and market integration.
He argued that fragmented regulations and inconsistent industrial policies continue to slow Africa’s manufacturing growth and limit intra-African trade opportunities.
According to the President, stronger cooperation among African states is necessary to unlock the continent’s manufacturing potential and reduce overreliance on external supply chains.
The push comes as African countries continue exploring ways to strengthen local pharmaceutical production following lessons learned during the COVID-19 pandemic, which exposed vulnerabilities in global medical supply systems.
Kenya has increasingly positioned itself as a key player in regional healthcare manufacturing, with growing investments in pharmaceuticals, medical technologies, and health research expected to drive the sector’s next phase of growth.
